For Research Use Only

EuroClonality-NDC assay

The EuroClonality-NDC assay allows you to detect immunoglobulin and T cell receptor rearrangements, translocations, mutations and copy number alterations in a single test.

About EuroClonality-NDC
Euroclonality backdrop

An integrated tool covering
most genomic alterations

The Myeloid-NDC assay is intended for the integrated detection of chromosomal translocations, copy number alterations and mutations in AML, MDS and MPN, from just 100 ng of DNA.

About Myeloid-NDC
Myeloid Backdrop

Universal Protocol Bespoke Solutions.

Bespoke NGS solutions for different clinical indications, without compromising in accuracy, content, performance or simplicity.

Download Resources
Univ8 pattern background

The future of fast accurate testing.

By encompassing all our NGS assays into a single universal workflow, you can achieve higher economy of scales and faster turnaround times for all your samples, irrespective of cancer type or laboratory throughput.
It’s that simple: 1 universal protocol, up to 8 bespoke assays, 2 days laboratory work, 1 day analysis… all done!

Contact Us

EuroClonality-NDC assay

Our first product, the EuroClonality-NDC assay can detect IG/TR rearrangements and translocations, sequence variants and copy number alterations, all in a single test.

Designed and developed by the EuroClonality-NGS working group.

Univ8 Genomics & EuroClonality logo

EuroClonality-NDC assay

Myeloid-NDC assay

Our first 2024 product, the Myeloid-NDC assay is intended for the integrated and qualitative detection of chromosomal translocations, copy number variants (CNV) and sequence variants from suspected or confirmed cases of myeloid malignancies.


Univ8 Genomics & Myeloid NDC logo

Myeloid-NDC assay


We are building our portfolio of NGS solutions for you, working hard on expanding the clinical indications to give you the full Univ8 Genomics experience.

If you would like to be kept informed of our developments please subscribe here: